Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25565765 | 0.95 | ALDH1A1 (0.35) | HRH3ALDH1A1KDM4ELMNA | |
| SCHEMBL25565746 | 0.85 | PAOX (0.36) | HRH3ALDH1A1 | |
| SCHEMBL20118757 | 0.85 | KDM4E (0.42) | HRH3ALDH1A1KDM4E | |
| SCHEMBL25565753 | 0.82 | ALDH1A1 (0.38) | HRH3ALDH1A1KDM4ELMNAADRB2 | |
| SCHEMBL25565758 | 0.81 | KDM4E (0.41) | HRH3ALDH1A1KDM4E | |
| SCHEMBL25569452 | 0.81 | PAOX (0.38) | HRH3ALDH1A1 | |
| SCHEMBL19546118 | 0.81 | PAOX (0.34) | HRH3ALDH1A1 | |
| SCHEMBL152809 | 0.81 | PAOX (0.40) | HRH3ALDH1A1LMNA | |
| SCHEMBL12028002 | 0.81 | KDM4E (0.42) | HRH3ALDH1A1KDM4ELMNA | |
| SCHEMBL25565757 | 0.79 | KDM4E (0.38) | ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | disclosed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | HRH3 3364/4885ALDH1A1 3979/4885KDM4E 4832/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | HRH3 4165/4885ALDH1A1 3422/4885KDM4E 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.